iBio Q1 EPS $(0.05) Beats $(0.08) Estimate, Sales $1.075M Beat $20.000K Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
iBio (AMEX:IBIO) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 54.55 percent increase over losses of $(0.11) per share from the same
iBio (AMEX:IBIO) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 54.55 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $1.075 million which beat the analyst consensus estimate of $20.000 thousand by 5.28K percent. This is a 975.00 percent increase over sales of $100.000 thousand the same period last year.